Article

SOM Biotech releases a new version of its proprietary drug repurposing process

Using the latest modular workflow technologies, SOM Biotech has released a new version of his proprietary drug repurposing virtual process. This update has had the goal to improve more than 30% the performance, scalability and velocity of the process.

This software update highlights the SOM Biotech strong commitment to grow day-by-day, in order to continue building a global leader in the field of Repurposing Drugs for Orphan Diseases.

If you are interested in a partnership or collaboration with, do not hesitate to get in touch.